ArticleAdvances in therapy2024

Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.

Philippe Moreau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.